Target
Egl nine homolog 1 [182-426]
Ligand
BDBM373636
Substrate
n/a
Meas. Tech.
PHD enzymatic assay
IC50
794±n/a nM
Citation
 Rabinowitz, MHRosen, MDTarantino, KTVenkatesan, H 4-Aminoquinazolin compounds as prolyl hydroxylase inhibitors US Patent  US10246442 Publication Date 4/2/2019 
Target
Name:
Egl nine homolog 1 [182-426]
Synonyms:
C1orf12 | EGLN1 | EGLN1_HUMAN | HIF-1alpha-PHD2
Type:
Enzyme Catalytic Domain
Mol. Mass.:
27392.37
Organism:
Homo sapiens (Human)
Description:
Q9GZT9[182-426]
Residue:
245
Sequence:
NGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF
  
Inhibitor
Name:
BDBM373636
Synonyms:
1-(7-Phenyl-4-(piperidin-1-yl)quinazolin-2-yl)-1H-pyrazole-4-carboxylic acid; | US10246442, Example 82 | US10975062, Example 82
Type:
Small organic molecule
Emp. Form.:
C23H21N5O2
Mol. Mass.:
399.4451
SMILES:
OC(=O)c1cnn(c1)-c1nc(N2CCCCC2)c2ccc(cc2n1)-c1ccccc1
Structure:
Search PDB for entries with ligand similarity: